Archive | Avandia RSS feed for this section
Government report links Avandia to heart attacks
The diabetes drug Avandia produced by GlaxoSmithKline is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released on 20., February of 2010. The senate report by the Senate Finance Committee also criticized the FDA, [...]
Continue reading...Avandia Drug Recall
20. January 2009
Avandia produced by GlaxoSmithKline, is an oral diabetes medication intended to help those with type-2 diabetes better control their blood glucose levels. Generically classified as a thiazoliodinedione, Avandia is not indicated for those with insulin-dependent (type-1) diabetes. FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came to [...]
Continue reading...Avandia has been linked to Heart Attacks
27. July 2008
Avandia (rosiglitazone maleate) is a popular diabetes drug made by GlaxoSmithKline. A recent study by the FDA has lead to nationwide Avandia recall as the tablets have been shown to cause serious side effects including an increased risk of heart attack and cardiovascular diseases.
Continue reading...
20. February 2010
0 Comments